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lower extremity edema. Some patients present acutely with renal fail-
ure and hydronephrosis secondary to mass effect and ureteral obstruc-
tion (Akram et al., 2007 May;5; Liu et al., 2014 Nov). Inﬂammatory
markers such as C-reactive protein and erythrocyte sedimentation rate
are often elevated in these patients. An elevated serum IgG-4 level
may be helpful in the diagnosis of IgG-4 related disease, although up
to 30% of these patients have normal serum levels. Computed tomogra-
phy scans are themost common imaging study used to aid in diagnosis.et al., 2012 Feb 9). These masses may also show calciﬁcations, retroper-Introduction
Sclerosing mesenteritis, inﬂammatory pseudotumor, retroperitoneal
ﬁbrosis and IgG-4 related disease are rare inﬂammatory conditions that
may present as a pelvic mass and mimic malignancy or infection. There
is considerable overlap between these inﬂammatory conditions often
leading to diagnostic and therapeutic confusion. Sclerosing mesenteritis
is characterized by chronic inﬂammation, ﬁbrosis and fat necrosis, and
is thought to originate from the small bowel mesentery (Akram et al.,
2007 May;5). Inﬂammatory pseudotumors are characterized histologi-
cally bymyoﬁbroblast-derived spindle cells and lymphoplasmacytic inﬁl-
trates. They may affect numerous organs of the body, most notably the
orbit and lung, and they are often mistaken for malignancy (Yagmur
et al., 2014). Retroperitoneal ﬁbrosis is characterized by ﬁbrosis and in-
ﬂammation of the retroperitoneum, often causing encasement of retro-
peritoneal organs including the ureters and aorta (Liu et al., 2014 Nov).
IgG 4-related disease is characterized by dense lymphoplasmacytic inﬁl-
trate, storiform (irregularly whorled) ﬁbrosis, and obliterative phlebitis
(Stone et al., 2012 Feb 9) (Carruthers et al., 2012 Jan).
Inﬂammatory diseases of the retroperitoneum typically occur in
men in the sixth to seventh decade of life, occurring twice as often in
men than woman. Some hypothesize that risk factors for sclerosing
mesenteritis may include autoimmunity, trauma, previous surgery,
infectious, and ischemic injury (Akram et al., 2007May;5). Patients typ-
ically present with progressive abdominal and ﬂank pain, abdominalYork, NY 10021, United States.
. This is an open access article underScansmay reveal connective tissue around the abdominal ureters, aorta,
or show a large mass that broadly occupies the retroperitoneum (Stone
itoneal and mesenteric lymphadenopathy, and increased collateral cir-
culation (Liu et al., 2014 Nov). While clinical suspicion and serologic
studies may help in diagnosis, histopathological features from a tissue
sample remain key to proving a diagnosis.
While these conditions can affect almost every organ system, gyne-
cologists will encounter them when a patient presents with a retroper-
itoneal pelvic mass. These masses are often unresectable, but as their
etiology is thought to be immune-mediated, they tend to respond well
to immunosuppressive therapy.Case
This is a 26 year-old gravida zero female who presented to her
gastroenterologist with left lower quadrant pain and fullness. She noted
constipation and 15-lb weight loss, but review of systems was otherwise
negative. She used an intrauterine device for contraception. Pastmedical,
surgical, gynecologic, family and social histories were non-contributory.
Her vital signs were within normal limits. Colonoscopy demonstrated
cobblestoning, but no overt inﬂammatory bowel disease. She was re-
ferred to gynecology, and subsequently gynecologic oncology. Pelvic
and rectovaginal exam revealed a 12-cm ﬁxed pelvicmass. Computed to-
mography scan demonstrated an 11.5 ×8.3 × 9.9 cmheterogeneous solid
and cystic pelvic mass, inseparable from the uterus, distorting the sig-
moid colon and bladder bymass effect (Fig. 1). Bilateralmild tomoderate
hydronephrosis, a small amount of abdomino-pelvic ascites, and pelvic
and retroperitoneal adenopathy were noted. Lab work was signiﬁcant
for leukocytosis with a white blood cell count of 22,500/μL and
thrombocytosis with a platelet count of 1,022,000/μL. Creatinine was
within normal limits. Erythrocyte sedimentation rate and C-reactivethe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Coronal post contrast enhanced CT image demonstrating heterogeneous ill‐deﬁned
pelvicmass. Associatedhigh‐density ﬂuid in the abdomenand right sided hydronephrosis.
Fig. 2. (a) Low-power view shows prominent chronic inﬂammation, dense ﬁbrosis and fat
lobules. (b) Onhigh-power view there are numerous plasma cells inﬁltratingmature fat in
the background of eosinophils and lymphocytes and ﬁbrosis. (c) IgG4 immunohistochem-
istry highlights IgG4‐positive plasma cells.
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markers, including cancer antigen-125, carcinoembryonic antigen, cancer
antigen 19-9, alpha-fetoprotein, beta-HCG, and lactate dehydrogenase,
were within normal limits.
Gynecologic oncology recommended surgical evaluation with
exploratory laparotomy and excision of themasswith plans for intraop-
erative pathology, and fertility-sparing staging and debulking as indi-
cated. The following day, she underwent cystoscopy with bilateral
ureteral stent placement followed by exploratory laparotomy. Explora-
tion of the abdominal cavity revealed a ﬁrm left-sided retroperitoneal
mass posterior and contiguous with the mesentery of the sigmoid
colon. Dissection of the mass away from the left pelvic sidewall and
the sigmoid colon was attempted, but there was no clear tissue plane
between the ﬁxed pelvic mass and the patient's normal pelvic anatomy.
Biopsies of the mass and the omentum were collected and sent to
pathology. An intra-operative general surgery consult was obtained
and conﬁrmed that the mass was unresectable.
Final pathology returned as sclerosing mesenteritis (inﬂammatory
pseudotumor). Numerous plasma cells positive for IgG-4 immunostain
were present (Fig. 2a,b,c). Pelvic washingswere negative formalignancy.
Given that sclerosing mesenteritis is presumed to be immune-mediated,
rheumatology was consulted during the patient's post-operative course.
Work-up by rheumatology included IgG-4 levels whichwerewithin nor-
mal limits. The patientwas treatedwith a two-week course of Aztreonam
and Flagyl as well as Prednisone 60 mg daily. The patient symptoms
improved, and she tapered and then stopped her steroids within two
months. At follow-up three months after initial presentation, the patient
reported complete resolution of her symptoms. Laboratory results dem-
onstrated normalization of her white blood count and platelets, and
MRI showed near complete resolution of the pelvic mass (Fig. 3a,b).
Comment
Inﬂammatory lesions in the retroperitoneal space, which can in-
clude retroperitoneal ﬁbrosis, sclerosing mesenteritis, inﬂammatory
pseudotumor, and IgG-4 related disease can mimic gynecologic malig-
nancies. Although there is overlap between these conditions, many
cases previously classiﬁed as other localized inﬂammatory conditions
are now thought to represent IgG-4 related disease (Stone et al., 2012Feb 9). In our case, the presence of IgG-4 bearing plasma cells on biopsy
argues for IgG-4 related disease but a deﬁnitive diagnosis could not be
made given the absence of storiform ﬁbrosis and obliterative phlebitis.
Therefore a diagnosis of sclerosing mesenteritis was made. First-line
treatment for IgG-4 related disease, and other retroperitoneal ﬁbro-
inﬂammatory conditions, is glucocorticoids. Steroid sparing agents
such as azathioprine, mycophenolate moteﬁl, methotrexate, and ritux-
imab are also used (Stone et al., 2012 Feb 9) (Khosroshahi et al., 2012
Fig. 3. (a) Sagittal image from a post contrastMRI demonstrating a heterogeneously enhancingmasswhich is inseparable from the uterus. (b)MRI performed3months later demonstrates
complete resolution of this mass.
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diseases may be mistaken for malignancy or infection. Yoshino et al.
published a case report in 2013 regarding a 71-year-old male who pre-
sented with gross hematuria, hydronephrosis and a large pelvic mass
surrounding the ureteropelvic junction, raising concern for a renal pel-
vic cancer. The patient declined biopsy or surgery, and due to a clinical
suspicion for IgG-4 related disease, given elevated serum IgG-4 serum
levels, he was treated with steroids. This patient achieved complete re-
gression of the mass, resolution of the hydronephrosis, and decrease in
serum IgG4 levels (Yoshino et al., 2013). Conversely, in 2013Wan et al.
published a case report regarding a patient with lymphoedema and
obstructive nephropathy from a large retroperitoneal mass who was
originally diagnosed with retroperitoneal ﬁbrosis based on clinical
suspicion and imaging. Subsequently, a CT guided biopsy was obtained
which revealed non-Hodgkin's lymphoma (Wan and Jiao, 2013). These
cases highlight the fact that while imaging and clinical features may
raise suspicion for a retroperitoneal inﬂammatory condition, a biopsy
must be obtained to ensure diagnosis.
Inﬂammation and ﬁbrosis, aswell as a tendency to encase surround-
ing structures,make surgicalmanagement of retroperitoneal inﬂamma-
tory conditions challenging and dangerous, as it has the potential to
damage adjacent organs such as ureters and bowel. In contrast, medical
treatment with immunosuppression is often successful, and can limit
the potential morbidity of surgical interventions. In a retrospective
and prospective, single-institution study examining treatment out-
comes in 92 patients diagnosedwith sclerosingmesenteritis, 45% of pa-
tients had surgery. In those patients who were surgically managed,
partial to complete resection of the mass was only possible in 30%. The
remaining 70 of patients had only segmental small bowel resection, pal-
liative bypass or adhesiolysis secondary to inability to resect themesen-
teric mass. Only two percent of patients who were surgically managedresponded to surgery alone. However, 41% of patients whowere treated
medically had clinical improvement (Akram et al., 2007 May;5).
Retroperitoneal inﬂammatory conditions are often triaged andman-
aged by rheumatologists, general surgeons, gastroenterologists and
urologists. This case is novel in that it mimicked a gynecologic malig-
nancy in a young woman. While histopathologic conﬁrmation of the
diagnosis is required, medical management is a safer andmore effective
treatment modality than surgery in these patients.
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